TGA / PMDA / NMPA · Asia-Pacific
vitamin — TGA / PMDA / NMPA regulatory status
vitamin regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 4
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 58 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| 100-006 | Phase 3 | Cardiol Therapeutics | 2024-517688-21-00 |
| Albendazole (400 mg) and/or Vitamin a | Phase 3 | United Therapeutics Europe | NCT00396500 |
| Cholecalciferol (Vitamin D/Vigantol oil) | Phase 3 | United Therapeutics Europe | NCT01069874 |
| H.22.03.01.09.A2 | Phase 3 | United Therapeutics Europe | NCT00128557 |
| Low-dose complex B-vitamins | Phase 3 | Chinese Academy of | NCT00755664 |
| UVEDOSE 100 000 UI, solution buvable en ampoule | Phase 3 | Novo Nordisk A/S | 2024-516793-30-00 |
| Vitamin A | Phase 3 | United Therapeutics Europe | NCT00707785 |
| Vitamin D3 | Phase 3 | Hospital Authority | NCT05326841 |
| vitamin D | Phase 3 | Takeda | NCT04536298 |
| RC03T001 | Phase 2 | Anaxis Pharma | 2023-510370-14-00 |
| RC04T001 | Phase 2 | Anaxis Pharma | 2023-509007-33-00 |
| Vitamin A (retinyl palmitate) | Phase 2 | United Therapeutics Europe | NCT00198718 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 2024249615 | EXOSOMES DE LAIT BOVIN POUR ADMINISTRER DE LA VITAMINE D | WO |
| 3256311 | MÉTHODES D'AMÉLIORATION DE LA SANTÉ OSSEUSE AU MOYEN DE PRODUITS ENRICHIS EN EXOSOMES DE LAIT BOVIN ET DE VITAMINE K2 | CA |
| 2024015441 | EXOSOMES DE LAIT BOVIN POUR L'ADMINISTRATION DE VITAMINE K2 ET L'AUGMENTATION DE LA BIODISPONIBILITÉ | WO |
| 4125971 | BAKTERIENSTÄMME, ZUSAMMENSETZUNGEN DAVON UND VERWENDUNG DAVON IN EINEM VERFAHREN ZUR BEHANDLUNG VON VITAMIN-D-MANGEL UND DAMIT ASSOZIIERTEN ERKRANKUNGEN | EP |
| 9855305 | Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors | US |
| 8835405 | Inhibiting arthritis via injection of synergistic combination of hyaluronic acid and vitamin C and/or vitamin E | US |
| 8404288 | Microbially-stable vitamin E solutions | US |
| 8202507 | Assay for vitamin B12 absorption and method of making labeled vitamin B12 | US |
| 8007853 | Vitamin/mineral composition with DHA | US |
| 7994217 | Prenatal multivitamin/multimineral supplement | US |
| 7704542 | Vitamin/mineral compositions with DHA | US |
| 7462345 | Radionuclide labeling of vitamin B12 and coenzymes thereof | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of vitamin?
vitamin currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get vitamin regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to vitamin?
This spoke lists 58 published programs associated with vitamin in our pipeline index.